Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01912287 · ClinicalTrials.gov registry record · NA
GATE: Generalized Anxiety - A Treatment Evaluation
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 226
- Enrollment target
NCT01912287: Completed NA study, sponsored by NYU Langone Health.
NCT01912287 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 226 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01912287, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 226 participants
- Enrollment target
Study Summary
The purpose of this randomized study is to examine the comparative efficacy of yoga, cognitive behavioral therapy, and stress education, a previously employed control condition, for patients with Generalized Anxiety Disorder.
Primary Outcome
Treatment response is a dichotomous outcome coded 0=no treatment response, 1= treatment response. This treatment response coding was derived from the Clinical Global Impression-Improvement (CGI-I) measure. The CGI-I is a clinician administered instrument that assesses level of symptom change across the course of treatment. The CGI-I ranges from 1 to 7, with lower scores indicating greater improvement. Our treatment response outcome variable was coded 0 if CGI-I was 3 or more. Treatment response
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy
- BEHAVIORAL Yoga
- BEHAVIORAL Stress Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 226 participants |
| Start Date | 2013-12 |
| Est. Completion | 2019-10-25 |
| Phase | NA |
What the finished NCT01912287 record still lists
NCT01912287 is an interventional study that assigns participants to a tested intervention. The registered 226 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).
The record links to 0 conditions, and to 3 interventions - of which Cognitive Behavioral Therapy is the first listed.
NCT01912287 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01912287 about?
NCT01912287 is a clinical study titled "GATE: Generalized Anxiety - A Treatment Evaluation". The purpose of this randomized study is to examine the comparative efficacy of yoga, cognitive behavioral therapy, and stress education, a previously employed control condition, for patients with Generalized Anxiety Disorder.
What is the current status of trial NCT01912287?
This trial is currently completed. It is a NA study. The enrollment target is 226 participants. The study started on 2013-12. Estimated completion is 2019-10-25.
What interventions are being tested in trial NCT01912287?
The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL), Yoga (BEHAVIORAL), Stress Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT01912287?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01912287's enrollment target sits among peer trials
226 471st of 2000 higher than 1,529 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04419272 · 226 participants · Phase 4
Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits
- NCT05449002 · 226 participants · NA
Digital Single Session Intervention for Youth Mental Health
- NCT05488054 · 226 participants · NA
Muscle O2 Saturation and Hemoglobin Levels During Rehabilitation From Arthroscopic Surgery
- NCT05924477 · 226 participants · NA
Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia